9 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
, Avenue continued to successfully execute across our pipeline of innovative CNS treatments," said Alexandra MacLean, M.D., Chief Executive Officer
FWP
ATXI
Avenue Therapeutics Inc
5 Oct 23
Free writing prospectus
5:05pm
tissues Misfolded / aggregated protein causes toxicity as well as nerve and muscle death AJ201’s innovative mechanism of action has potential
FWP
ATXI
Avenue Therapeutics Inc
3 Oct 23
Free writing prospectus
5:47pm
tissues Misfolded / aggregated protein causes toxicity as well as nerve and muscle death AJ201’s innovative mechanism of action has potential
8-K
EX-99.1
55dzzamb7
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
EX-99.1
b5fdnr
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
EX-99.1
t1ld1
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
f5a2ycsv bsm
12 Mar 19
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
9:16am
- Prev
- 1
- Next